This was associated with an MSH6 mutation, CCDS1836.1 c.1592C > T, p.P531L, that was undetected in the initial tumor and correlated with loss of MSH6 and MSH2 protein immunoreactivity in the recurrent tumor only (Fig. 2). This evidence concerns the gene MSH2 and neoplasm.